Oxford Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438K | Buy |
+20,201
| New | +$438K | 0.16% | 213 |
|
|
2020
Q1 | – | Sell |
-259,439
| Closed | -$973K | – | 449 |
|
|
2019
Q4 | $973K | Buy |
259,439
+108,409
| +72% | +$407K | 0.03% | 874 |
|
|
2019
Q3 | $802K | Sell |
151,030
-24,923
| -14% | -$132K | 0.02% | 1048 |
|
|
2019
Q2 | $676K | Buy |
+175,953
| New | +$676K | 0.01% | 1147 |
|
|
2018
Q4 | – | Sell |
-353,962
| Closed | -$1.34M | – | 1827 |
|
|
2018
Q3 | $1.34M | Sell |
353,962
-336,438
| -49% | -$1.27M | 0.03% | 874 |
|
|
2018
Q2 | $2.15M | Buy |
690,400
+38,801
| +6% | +$121K | 0.04% | 621 |
|
|
2018
Q1 | $1.56M | Buy |
651,599
+476,132
| +271% | +$1.14M | 0.03% | 711 |
|
|
2017
Q4 | $696K | Buy |
175,467
+37,138
| +27% | +$147K | 0.02% | 1079 |
|
|
2017
Q3 | $344K | Buy |
138,329
+52,161
| +61% | +$130K | 0.01% | 1309 |
|
|
2017
Q2 | $238K | Buy |
86,168
+27,228
| +46% | +$75.2K | ﹤0.01% | 1317 |
|
|
2017
Q1 | $115K | Buy |
58,940
+34,181
| +138% | +$66.7K | ﹤0.01% | 1349 |
|
|
2016
Q4 | $26K | Buy |
+24,759
| New | +$26K | ﹤0.01% | 751 |
|
|
2016
Q3 | – | Sell |
-180,721
| Closed | -$128K | – | 779 |
|
|
2016
Q2 | $128K | Buy |
180,721
+6,140
| +4% | +$4.35K | ﹤0.01% | 723 |
|
|
2016
Q1 | $204K | Buy |
+174,581
| New | +$204K | 0.01% | 710 |
|